Universitat Pompeu Fabra
2024-03-15T09:52:22Z
2024-03-15T09:52:22Z
2018
The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non–human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies.
Article
Published version
English
Clinical research/practice; Translational research/science; Histocompatibility; Solid organ transplantation; Immunobiology; Alloantibody; B-cell biology; Desensitization; Guidelines; T-cell biology
Elsevier
Am J Transplant. 2023 Jan;23(1):133-49
© 2022 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
http://creativecommons.org/licenses/by-nc-nd/4.0/
